Pnc Financial Services Group, Inc. Meridian Bioscience Inc Transaction History

Pnc Financial Services Group, Inc.

$150 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$31.15 - $33.39 $691,125 - $740,823	-22,187 Reduced 61.74%	13,750 $456,000
Q3 2022 Nov 10, 2022	SELL	$30.9 - $33.55 $271,271 - $294,535	-8,779 Reduced 19.63%	35,937 $1.13 Million
Q2 2022 Aug 12, 2022	SELL	$23.75 - $31.69 $223,915 - $298,773	-9,428 Reduced 17.41%	44,716 $1.36 Million
Q1 2022 May 12, 2022	SELL	$19.97 - $26.94 $273,429 - $368,862	-13,692 Reduced 20.18%	54,144 $1.41 Million
Q4 2021 Feb 11, 2022	SELL	$17.46 - $21.61 $35,164 - $43,522	-2,014 Reduced 2.88%	67,836 $1.38 Million
Q3 2021 Nov 05, 2021	SELL	$17.35 - $22.5 $41,761 - $54,157	-2,407 Reduced 3.33%	69,850 $1.34 Million
Q2 2021 Aug 06, 2021	SELL	$18.01 - $28.32 $15,272 - $24,015	-848 Reduced 1.16%	72,257 $1.6 Million
Q1 2021 May 07, 2021	SELL	$19.76 - $29.89 $17,724 - $26,811	-897 Reduced 1.21%	73,105 $1.92 Million
Q4 2020 Feb 12, 2021	BUY	$15.73 - $21.66 $503 - $693	32 Added 0.04%	74,002 $1.38 Million
Q3 2020 Nov 06, 2020	SELL	$13.54 - $26.41 $15,246 - $29,737	-1,126 Reduced 1.5%	73,970 $1.26 Million
Q2 2020 Aug 07, 2020	SELL	$7.84 - $23.29 $168,599 - $500,851	-21,505 Reduced 22.26%	75,096 $1.75 Million
Q1 2020 May 08, 2020	SELL	$5.57 - $11.5 $8,466 - $17,480	-1,520 Reduced 1.55%	96,601 $811,000
Q4 2019 Feb 07, 2020	BUY	$7.9 - $10.14 $11,913 - $15,291	1,508 Added 1.56%	98,121 $958,000
Q3 2019 Nov 08, 2019	BUY	$9.17 - $12.01 $1,476 - $1,933	161 Added 0.17%	96,613 $916,000
Q2 2019 Aug 09, 2019	SELL	$10.88 - $17.6 $17,560 - $28,406	-1,614 Reduced 1.65%	96,452 $0
Q1 2019 May 10, 2019	SELL	$15.51 - $17.61 $4,203 - $4,772	-271 Reduced 0.28%	98,066 $0
Q4 2018 Feb 08, 2019	SELL	$14.52 - $19.72 $14,432 - $19,601	-994 Reduced 1.0%	98,337 $1.71 Million
Q3 2018 Nov 09, 2018	SELL	$14.85 - $16.35 $239,812 - $264,036	-16,149 Reduced 13.98%	99,331 $0
Q2 2018 Aug 10, 2018	SELL	$13.8 - $16.8 $524 - $638	-38 Reduced 0.03%	115,480 $0
Q1 2018 May 11, 2018	SELL	$13.8 - $16.2 $14,076 - $16,524	-1,020 Reduced 0.88%	115,518 $0
Q4 2017 Feb 09, 2018	BUY	$13.55 - $15.8 $157,925 - $184,149	11,655 Added 11.11%	116,538 $0
Q3 2017 Nov 13, 2017	BUY	$13.45 - $14.35 $1.41 Million - $1.51 Million	104,883	104,883 $0

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account